Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT

Borderline Personality Disorder Clinical Trial

— DBT_dropout2  

Official title:

Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05289583
• Other study ID #: DBT_dropout2
• Status: Completed
• Start date: January 1, 2019
• Est. completion date: February 28, 2022

Study information

• Verified date: March 2022
• Source: Evangelisches Krankenhaus Bielefeld gGmbH
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 44
• Est. completion date: February 28, 2022
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• three or more criteria for BPD as defined by DSM-5 (Borderline Personality characteristics; BPC)

Exclusion Criteria:

• inability to contract and consent,

• other severe mental disorders (bipolar disorder, acute psychosis),

• current alcohol,

• illicit or not prescribed drug use,

• simultaneous participation in other treatment studies,

• pregnancy or breastfeeding,

• an inability to negotiate a non-suicide agreement,

• ongoing traumatic contact with the perpetrator, and

• a Body Mass Index < 16.5.

Related Conditions & MeSH terms

• Borderline Personality Disorder
• Dropout
• Personality Disorders
• Psychotherapy

Intervention

Behavioral:
• Dialectical Behavior Therapy
DBT is a cognitive-behavioral treatment program that was developed to treat suicidal Patients with BPD (Linehan, 1993).

Locations

Country	Name	City	State
Germany	Research Department	Bielefeld

Sponsors (1)

Lead Sponsor	Collaborator
Evangelisches Krankenhaus Bielefeld gGmbH

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of Dropout	premature termination of treatment	8-10 weeks